362 related articles for article (PubMed ID: 15198372)
1. Type 1 diabetic neuropathy and C-peptide.
Sima AA; Zhang W; Grunberger G
Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
[TBL] [Abstract][Full Text] [Related]
2. Pathological mechanisms involved in diabetic neuropathy: can we slow the process?
Sima AA
Curr Opin Investig Drugs; 2006 Apr; 7(4):324-37. PubMed ID: 16625819
[TBL] [Abstract][Full Text] [Related]
3. Effects of C-peptide on microvascular blood flow and blood hemorheology.
Forst T; Kunt T
Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
[TBL] [Abstract][Full Text] [Related]
4. C-peptide and diabetic neuropathy.
Sima AA
Expert Opin Investig Drugs; 2003 Sep; 12(9):1471-88. PubMed ID: 12943492
[TBL] [Abstract][Full Text] [Related]
5. C-peptide, Na+,K(+)-ATPase, and diabetes.
Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
[TBL] [Abstract][Full Text] [Related]
6. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
Sima AA; Zhang W; Sugimoto K; Henry D; Li Z; Wahren J; Grunberger G
Diabetologia; 2001 Jul; 44(7):889-97. PubMed ID: 11508275
[TBL] [Abstract][Full Text] [Related]
7. Diabetic neuropathy differs in type 1 and type 2 diabetes.
Sima AA; Kamiya H
Ann N Y Acad Sci; 2006 Nov; 1084():235-49. PubMed ID: 17151305
[TBL] [Abstract][Full Text] [Related]
8. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes.
Kamiya H; Zhang W; Sima AA
Ann Neurol; 2004 Dec; 56(6):827-35. PubMed ID: 15497155
[TBL] [Abstract][Full Text] [Related]
9. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
Zhang W; Kamiya H; Ekberg K; Wahren J; Sima AA
Diabetes Metab Res Rev; 2007 Jan; 23(1):63-70. PubMed ID: 16845685
[TBL] [Abstract][Full Text] [Related]
10. C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
Kamiya H; Zhang W; Ekberg K; Wahren J; Sima AA
Diabetes; 2006 Dec; 55(12):3581-7. PubMed ID: 17130507
[TBL] [Abstract][Full Text] [Related]
11. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.
Kamiya H; Murakawa Y; Zhang W; Sima AA
Diabetes Metab Res Rev; 2005; 21(5):448-58. PubMed ID: 15747389
[TBL] [Abstract][Full Text] [Related]
12. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes.
Sima AA; Kamiya H; Li ZG
Eur J Pharmacol; 2004 Apr; 490(1-3):187-97. PubMed ID: 15094085
[TBL] [Abstract][Full Text] [Related]
13. Neuropathology of diabetic neuropathy and its correlations with neurophysiology.
Sima AA; Cherian PV
Clin Neurosci; 1997; 4(6):359-64. PubMed ID: 9358980
[TBL] [Abstract][Full Text] [Related]
14. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
[TBL] [Abstract][Full Text] [Related]
15. C-peptide and central nervous system complications in diabetes.
Li ZG; Sima AA
Exp Diabesity Res; 2004; 5(1):79-90. PubMed ID: 15198373
[TBL] [Abstract][Full Text] [Related]
16. New aspects on biological activity of C-peptide in IDDM patients.
Forst T; Kunt T; Pfützner A; Beyer J; Wahren J
Exp Clin Endocrinol Diabetes; 1998; 106(4):270-6. PubMed ID: 9792458
[TBL] [Abstract][Full Text] [Related]
17. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration.
Skundric DS; Lisak RP
Exp Diabesity Res; 2003; 4(4):303-12. PubMed ID: 14668051
[TBL] [Abstract][Full Text] [Related]
18. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
[TBL] [Abstract][Full Text] [Related]
19. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor system and neurological complications in diabetes.
Sima AA; Li ZG; Zhang W
Exp Diabesity Res; 2003; 4(4):235-56. PubMed ID: 14668047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
